Answers are grounded in this paper and cite their sources.
None of the studied biomarkers had sufficient sensitivity and specificity to diagnose AMI, although some biomarkers showed moderate predictive accuracy. Future studies should focus on timing of measurements of biomarkers, distinguishing between early stage and transmural necrosis, and between different types of AMI. Additionally, studies on combinations of biomarkers are warranted. PROSPERO registration: CRD42022379341.
No takes yet. Share an insight, caveat, or question.
Blaser et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: